Price
CHART BY
Historical dividends and forecast
Zoetis has so far distributed $1.59 in 2026. The next dividend will be paid on 02.12.2026
$1.05
CHART BY
Frequently asked questions
What is Zoetis's market capitalization?
The market capitalization of Zoetis is $30.29B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Zoetis's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Zoetis is 12.06. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Zoetis?
Zoetis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.079. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Zoetis's stock?
Currently, 20 analysts cover Zoetis's stock, with a consensus target price of $91.00. Analyst ratings provide insights into the stock's expected performance.
What is Zoetis's revenue over the trailing twelve months?
Over the trailing twelve months, Zoetis reported a revenue of $9.52B.
What is the EBITDA for Zoetis?
Zoetis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.07B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Zoetis?
Zoetis has a free cash flow of $2.37B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Zoetis have, and what sector and industry does it belong to?
Zoetis employs approximately 14,500 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Zoetis's shares?
The free float of Zoetis is 412.26M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $30.29B
- EPS (TTM)
- $6.079
- Free Float
- 412.26M
- P/E ratio (TTM)
- 12.06
- Revenue (TTM)
- $9.52B
- EBITDA (TTM)
- $4.07B
- Free Cashflow (TTM)
- $2.37B
Pricing
- 1D span
- $72.60$73.67
- 52W span
- $71.00$148.75
Analyst Ratings
The price target is $91.00 and the stock is covered by 20 analysts.
Buy
9
Hold
11
Sell
0
Information
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
- Employees
- 14,500
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- ZTS
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet